NDC 80425-0316-01 - Doxepin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0316
- Requested NDC
- 80425-0316-01
- Package NDCs from labels
- 80425-0316-1, 80425-0316-2, 80425-0316-3, 80425-0316-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxepin Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0316-1 | Doxepin Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | 2 | |
| 80425-0316-2 | Doxepin Hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | 2 | |
| 80425-0316-3 | Doxepin Hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0316 | DOXEPIN HYDROCHLORIDE CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f900bac4-02f2-6bf3-e053-6394a90a2161.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0316-1 | EA - Each | 80425-0316 | 28464baa-062f-4d04-b030-cd4f5b80a754 | 1 | 2023-06-06 |
| 80425-0316-2 | EA - Each | 80425-0316 | 7bca9d58-efc4-4209-8a21-2693fc3e32f3 | 1 | 2023-06-06 |
| 80425-0316-3 | EA - Each | 80425-0316 | f2b33fc2-fff3-4425-b00a-1fb444945861 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Silenor | DOXEPIN HYDROCHLORIDE | Currax Pharmaceuticals LLC | 1bec1223-5239-4eb6-a9e8-62444106d2c0 | 2026-04-21 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | c577af7c-2405-4454-a169-5b6a4fa0c7bf | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Safecor Health, LLC | a2297f75-c498-419b-aa29-057271313a7f | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 1ede17e6-19e9-455c-ad16-8029a590735c | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | d2a91b99-513d-4894-ad6d-02d2028a2290 | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin | DOXEPIN | North Star Rx LLC | 12edd5c6-c863-b83a-e063-6294a90a2f36 | 2025-12-30 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Leading Pharma, LLC | e6a4cb10-1928-4abe-8797-404c9ddc37dd | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Leading Pharma, LLC | d5df4beb-8048-4b83-aa59-19876437001d | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 1496dfc1-de50-471c-be87-1f1e2b70ab5a | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | A-S Medication Solutions | e0460c02-3dae-4b19-845c-2ffcfb587f6d | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Redpharm Drug | 37451a61-ccb1-57b3-e063-6294a90a2592 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Chartwell RX, LLC | 33a15c3f-bec0-4703-a4e9-f8f78f8b5fd3 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Ajanta Pharma USA Inc. | 1513c98c-e7ef-4009-b932-6757048bb86a | 2025-11-17 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8f7e9677-cc84-414b-8eb8-33993d285bb3 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin | DOXEPIN | Marlex Pharmaceuticals, Inc. | 06e79a65-1455-804e-e063-6394a90a2f3d | 2025-11-07 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 09a70f17-f934-4b4b-9277-6351d906ab47 | 2025-10-24 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 55f7d7b5-b747-49ac-9bf0-1510987b0291 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 1533343b-f1ed-4c3a-bb36-23a748452b05 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 94ee3c14-0ccc-4329-b012-63679a699a67 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | First Nation Group, LLC | 3d4f84a4-07a1-4d0e-85f5-dcd43b236a42 | 2025-09-14 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.